Protein kinase inhibitors infused intraventricularly or into the ventromedial hypothalamus block short latency facilitation of lordosis by oestradiol

J Neuroendocrinol. 2019 Dec;31(12):e12809. doi: 10.1111/jne.12809. Epub 2019 Nov 12.


An injection of unesterified oestradiol (E2 ) facilitates receptive behaviour in E2 benzoate (EB)-primed, ovariectomised female rats when it is administered i.c.v. or systemically. The present study tested the hypothesis that inhibitors of protein kinase A (PKA), protein kinase G (PKG) or the Src/mitogen-activated protein kinase (MAPK) complex interfere with E2 facilitation of receptive behaviour. In Experiment 1, lordosis induced by i.c.v. infusion of E2 was significantly reduced by i.c.v. administration of Rp-cAMPS, a PKA inhibitor, KT5823, a PKG inhibitor, and PP2 and PD98059, Src and MAPK inhibitors, respectively, between 30 and 240 minutes after infusion. In Experiment 2, we determined whether the ventromedial hypothalamus (VMH) is one of the neural sites at which those intracellular pathways participate in lordosis behaviour induced by E2 . Administration of each of the four protein kinase inhibitors into the VMH blocked facilitation of lordosis induced by infusion of E2 also into the VMH. These data support the hypothesis that activation of several protein kinase pathways is involved in the facilitation of lordosis by E2 in EB-primed rats.

Keywords: Src tyrosine kinase; lordosis behaviour; mitogen-activated protein kinase; oestradiol; protein kinase A; protein kinase G; protein kinase inhibitor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carbazoles / pharmacology
  • Cyclic AMP / analogs & derivatives
  • Cyclic AMP / pharmacology
  • Estradiol / physiology
  • Estrogen Antagonists / pharmacology*
  • Female
  • Flavonoids / pharmacology
  • Infusions, Intraventricular
  • Lordosis / chemically induced
  • Lordosis / physiopathology*
  • Male
  • Microinjections
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / pharmacology*
  • Pyrimidines / pharmacology
  • Rats
  • Thionucleotides / pharmacology
  • Ventromedial Hypothalamic Nucleus / drug effects
  • Ventromedial Hypothalamic Nucleus / physiology*


  • AG 1879
  • Carbazoles
  • Estrogen Antagonists
  • Flavonoids
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Thionucleotides
  • KT 5823
  • adenosine-3',5'-cyclic phosphorothioate
  • Estradiol
  • Cyclic AMP
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one